A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas

Overview of attention for article published in Cancers, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 5 X users
patent: 2 patents

facebook: 1 Facebook page

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 56,539 followers.

RT @Cancers_MDPI: Varun Monga @uiowa "The combination of VPA, bevacizumab, gemcitabine, and docetaxel appears to be moderately safe and wel…

Varun Monga @uiowa "The combination of VPA, bevacizumab, gemcitabine, and docetaxel appears to be moderately safe and well tolerated." A Phase I/II Study Targeting Angiogenesis: See https://t.co/z1xV0A4MPU

RT @MDPIOpenAccess: A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibi…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.